Tolerability and safety of sustained-release bupropion in the management of smoking cessation

Drugs

Volumn 62, Issue SUPPL. 2, 2002, Pages 45-52

  Aubin, Henri Jean ^a  

^a Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; PLACEBO;

ANXIETY NEUROSIS; BLOOD PRESSURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DREAM; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FLU LIKE SYNDROME; HEADACHE; HEART RATE; HUMAN; HYPERSENSITIVITY REACTION; INCIDENCE; INSOMNIA; MAJOR CLINICAL STUDY; NAUSEA; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; REVIEW; RISK FACTOR; SEIZURE; SMOKING CESSATION; SUSTAINED RELEASE PREPARATION; TOBACCO DEPENDENCE; UNITED STATES; VERTIGO; VIRUS INFECTION; XEROSTOMIA;

NICOTIANA TABACUM;

EID: 0036325907     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262002-00005     Document Type: Review

References (27)

1. Efficacy and safety of bupropion SR for smoking cessation: Data from clinical trials and 5 years of postmarketing experience
2. A comparison of sustained-release bupropion and placebo for smoking cessation
3. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
4. Buproprion hydrochloride is effective and well tolerated aid to smoking cessation: A multi-centre study
5. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study
6. Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation: A randomized, controlled trial
7. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomised trial
8. Bupropion hydrochloride induced serum sickness-like reaction
9. Serum sickness-like reaction with bupropion
10. Bupropion-induced hypersensitivity reactions
11. Bupropion and serum sickness-like reaction
12. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression
13. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm)
14. Targeting heavy smokers in general practice: Randomised controlled trial of transdermal nicotine patches
15. The safety, tolerability and efficacy of transdermal nicotine (Nicotinell TTS) in initially hospitalised patients
16. Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure
17. Cardiovascular effects of bupropion in depressed patients with heart disease
18. Clinical pharmacology of bupropion and imipramine in elderly depressives
19. Bupropion safety information
20. Development of depression during placebo-controlled trials of bupropion for smoking cessation: Case reports
21. Depression and smoking